Memory B Cells in Multiple Sclerosis: Emerging Players in Disease Pathogenesis.

Area of Science:

• Neuroimmunology
• Cellular immunology

Background:

• Multiple Sclerosis (MS) is a central nervous system inflammatory demyelinating disease.
• B cells, not just T cells, are increasingly recognized as critical in MS immunopathogenesis.
• The efficacy of CD20-targeting therapies highlights the role of B cells, particularly non-antibody secreting ones.

Purpose of the Study:

• To review the development, phenotypes, and effector functions of memory B cells (Bmem).
• To examine the potential roles of Bmem in MS pathogenesis within the periphery and central nervous system (CNS).
• To discuss how immunomodulatory therapies impact Bmem and inform future therapeutic strategies.

Main Methods:

• Literature review focusing on B cell phenotypes and functions in MS.
• Analysis of Bmem development, characteristics, and effector mechanisms.
• Examination of Bmem roles in both MS patients and animal models.

Main Results:

• Bmem possess diverse functions including cytokine production and antigen presentation.
• Bmem are antigen-experienced, long-lived cells with rapid responses.
• Bmem are implicated in MS pathogenesis through their activities in the periphery and CNS.

Conclusions:

• Memory B cells are crucial in MS pathogenesis, exhibiting multifaceted roles.
• Understanding Bmem functions is vital for developing targeted MS therapies.
• Future research should focus on Bmem-directed strategies for MS treatment.